Skip to main content

Hold On

 Sometimes you just have to sit tight and hold on, and that's exactly where I am at with both DXB and BOT.

Yes, both have passed the 20% gain and so, under my plan, they should be sold. However, both still have significant movements to make in the near future.

With BOT, we know the date: late June for FDA approval and a massive jump in the share price.

With DXB: they are currently negotiating licencing deals for the USA and for China. As each of those deals gets signed, there will be large movements in the share price. But the timing is uncertain. All we know is that the boys are in the back room and cruching the numbers. In reality, a deal will not be far away at all.

Plus...

Looking at another one I recommended to a friend: AUQ. At the time of writing, sitting at 7.1 cents. I expect this one to improve by 50% in the next 2 months (roughly the same timeframe as BOT - although BOT has a much bigger upside).

So, tke a deep breath and hold on, here's where the ride gets really exciting.

Comments

Popular posts from this blog

A Couple of Updates

 Well, it's Monday morning and the week has started with a bang. First, PFE announced that there was an unexpected problem with their test drill and they have had to abandon that and go to a new test drill site. A delay, but no real issue apart from that. And the market hated that. Good news for those wanting to buy, not so good for existing holders. IMC released their AGM presentation which indicates that there will be some news in December and then a very busy (and hopefully productive) 2025. Sales are good and continuing to get better and better.

2025 - an early start

 Ok., so here we go on my Trump-era goal. Just bought MXR (yes, on the ASX). AAR wants to take them over at 7 cents as a scrip payment (paying in AAR shares instead of cash). The current share price is 6.3 cents. So that should be a quick 10% gain. However... this does look like a lowball offer and may yet be increased. MXR has great assets and AAR already owns almost 20% of MXR. So AAR is committed to a deal and that may just attract other attention. It looks like a no-brainer to start 2025. Yes, there is always some risk, but this one looks pretty good. I have done a bit more research and have some exciting thoughts, including one that looks a little like another WGO (which returned handsomely on a takeover). More news coming as I do more reseach.  Another one that looks good for a quick profit is GES, but as I write this, there are no shares at the right price (.05).

Out of 2

 I ahd some bills to pay and these 2 got the chop: PFE - such promise, such disappointmen IMC - I always had some ethical problems with this one.  But there it is. Bills paid, and a little left over to find something new with.